NCT04717882 (iLIVEmed) is a NA clinical trial of CDSS-OPTIMED in Palliative Care, sponsored by Prof. dr. Stefan Sleijfer.

Who is sponsoring NCT04717882?

NCT04717882 is sponsored by Prof. dr. Stefan Sleijfer.

What drugs are being tested in NCT04717882?

Interventions in NCT04717882: CDSS-OPTIMED.

What condition does NCT04717882 study?

NCT04717882 studies Palliative Care.

Is NCT04717882 still recruiting?

NCT04717882 is currently status unknown. Last updated 22 January 2021.

Last reviewed 2021-01-22 · How we verify

NCT04717882: iLIVEmed

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iLIVE Medication Study

Status unknown NA Last updated 22 January 2021

What this trial tests

NA trial testing CDSS-OPTIMED in Palliative Care in 400 participants. Status unknown.

Timeline

15 January 2021

Primary endpoint
15 January 2023

15 January 2024

Quick facts

Lead sponsor	Prof. dr. Stefan Sleijfer
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	supportive care
Enrollment	400
Start date	15 January 2021
Primary completion	15 January 2023
Estimated completion	15 January 2024
Sites	3 locations across Sweden, Netherlands, Switzerland

Drugs / interventions tested

CDSS-OPTIMED

Conditions studied

Palliative Care — all drugs for Palliative Care →

Sponsor

Prof. dr. Stefan Sleijfer

Who can join

18 and older, any sex, with Palliative Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The iLIVE medication study is a before-after study where medication optimisation of patients with an estimated life expectancy of six months is investigated. The investigators will include 400 patients in 3 countries. The primary outcome is an assessment of the quality of life of patients, four weeks after baseline assessment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CDSS-OPTIMED

Trials testing the same drug.

NCT05351281 — Appropriate Medication Use in Dutch Terminal Care · NA · completed

Other recruiting trials for Palliative Care

Currently open trials in the same condition.

NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting
NCT07469761 — MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care · NA · recruiting
NCT06588556 — Improving Needs Among Older Adults · NA · recruiting
NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04717882 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. dr. Stefan Sleijfer
Last refreshed: 22 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04717882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing